261 related articles for article (PubMed ID: 37248302)
1. Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.
Okuzumi A; Hatano T; Matsumoto G; Nojiri S; Ueno SI; Imamichi-Tatano Y; Kimura H; Kakuta S; Kondo A; Fukuhara T; Li Y; Funayama M; Saiki S; Taniguchi D; Tsunemi T; McIntyre D; Gérardy JJ; Mittelbronn M; Kruger R; Uchiyama Y; Nukina N; Hattori N
Nat Med; 2023 Jun; 29(6):1448-1455. PubMed ID: 37248302
[TBL] [Abstract][Full Text] [Related]
2. Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies.
Huang J; Yuan X; Chen L; Hu B; Wang H; Wang Y; Huang W
Exp Gerontol; 2024 Mar; 187():112366. PubMed ID: 38280659
[TBL] [Abstract][Full Text] [Related]
3. Neuropathology and molecular diagnosis of Synucleinopathies.
Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
[TBL] [Abstract][Full Text] [Related]
4. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.
Rossi M; Candelise N; Baiardi S; Capellari S; Giannini G; Orrù CD; Antelmi E; Mammana A; Hughson AG; Calandra-Buonaura G; Ladogana A; Plazzi G; Cortelli P; Caughey B; Parchi P
Acta Neuropathol; 2020 Jul; 140(1):49-62. PubMed ID: 32342188
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
Poggiolini I; Gupta V; Lawton M; Lee S; El-Turabi A; Querejeta-Coma A; Trenkwalder C; Sixel-Döring F; Foubert-Samier A; Pavy-Le Traon A; Plazzi G; Biscarini F; Montplaisir J; Gagnon JF; Postuma RB; Antelmi E; Meissner WG; Mollenhauer B; Ben-Shlomo Y; Hu MT; Parkkinen L
Brain; 2022 Apr; 145(2):584-595. PubMed ID: 34894214
[TBL] [Abstract][Full Text] [Related]
6. RT-QuIC and Related Assays for Detecting and Quantifying Prion-like Pathological Seeds of α-Synuclein.
Srivastava A; Alam P; Caughey B
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454165
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy.
Luan M; Sun Y; Chen J; Jiang Y; Li F; Wei L; Sun W; Ma J; Song L; Liu J; Liu B; Pei Y; Wang Z; Zhu L; Deng J
Mov Disord; 2022 May; 37(5):1059-1063. PubMed ID: 35278004
[TBL] [Abstract][Full Text] [Related]
8. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
9. Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.
Gibbons CH; Levine T; Adler C; Bellaire B; Wang N; Stohl J; Agarwal P; Aldridge GM; Barboi A; Evidente VGH; Galasko D; Geschwind MD; Gonzalez-Duarte A; Gil R; Gudesblatt M; Isaacson SH; Kaufmann H; Khemani P; Kumar R; Lamotte G; Liu AJ; McFarland NR; Miglis M; Reynolds A; Sahagian GA; Saint-Hillaire MH; Schwartzbard JB; Singer W; Soileau MJ; Vernino S; Yerstein O; Freeman R
JAMA; 2024 Apr; 331(15):1298-1306. PubMed ID: 38506839
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G;
Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335
[TBL] [Abstract][Full Text] [Related]
11. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
[TBL] [Abstract][Full Text] [Related]
12. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
Foulds PG; Yokota O; Thurston A; Davidson Y; Ahmed Z; Holton J; Thompson JC; Akiyama H; Arai T; Hasegawa M; Gerhard A; Allsop D; Mann DM
Neurobiol Dis; 2012 Jan; 45(1):188-95. PubMed ID: 21856424
[TBL] [Abstract][Full Text] [Related]
13. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies.
Bargar C; Wang W; Gunzler SA; LeFevre A; Wang Z; Lerner AJ; Singh N; Tatsuoka C; Appleby B; Zhu X; Xu R; Haroutunian V; Zou WQ; Ma J; Chen SG
Acta Neuropathol Commun; 2021 Apr; 9(1):62. PubMed ID: 33827706
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC.
Donadio V; Wang Z; Incensi A; Rizzo G; Fileccia E; Vacchiano V; Capellari S; Magnani M; Scaglione C; Stanzani Maserati M; Avoni P; Liguori R; Zou W
Neurology; 2021 May; 96(20):e2513-e2524. PubMed ID: 33837116
[TBL] [Abstract][Full Text] [Related]
15. Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders.
Manne S; Kondru N; Hepker M; Jin H; Anantharam V; Lewis M; Huang X; Kanthasamy A; Kanthasamy AG
J Neuroimmune Pharmacol; 2019 Sep; 14(3):423-435. PubMed ID: 30706414
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review.
Singer W
Clin Auton Res; 2022 Aug; 32(4):291-297. PubMed ID: 35895157
[TBL] [Abstract][Full Text] [Related]
17. The promise of amplification assays for accurate early detection of α-synucleinopathies: A review.
Kurapova R; Chouliaras L; O'Brien JT
Exp Gerontol; 2022 Aug; 165():111842. PubMed ID: 35623540
[TBL] [Abstract][Full Text] [Related]
18. Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease.
Hall S; Orrù CD; Serrano GE; Galasko D; Hughson AG; Groveman BR; Adler CH; Beach TG; Caughey B; Hansson O
Acta Neuropathol Commun; 2022 Jun; 10(1):90. PubMed ID: 35733234
[TBL] [Abstract][Full Text] [Related]
19. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA
Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869
[TBL] [Abstract][Full Text] [Related]
20. Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease.
Wang Z; Becker K; Donadio V; Siedlak S; Yuan J; Rezaee M; Incensi A; Kuzkina A; Orrú CD; Tatsuoka C; Liguori R; Gunzler SA; Caughey B; Jimenez-Capdeville ME; Zhu X; Doppler K; Cui L; Chen SG; Ma J; Zou WQ
JAMA Neurol; 2020 Sep; 78(1):1-11. PubMed ID: 32986090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
